Are Institutions Curtailing Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock?

According to the latest SEC Filings, firms & funds owning shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) have decreased their positions by -0.56%.  Institutions now own 7.30% of the company.

Investors have a few distinct options when approaching the stock market. One option is to follow the crowd and trade with the consensus. Another way is to go against the herd and adopt a contrarian strategy. When it comes down to it, the investor will typically have to make this decision with their best interests in mind. In general, no investor wants to miss out on a winning stock. Far too often, investors will be overcome with the fear of missing out and get into a stock way too late. Just because a stock has been over performing and seeing large gains does not mean that those gains are going to continue into the future. Investors may be too quick to get into a hot stock without putting in the proper time and energy to research whether or not it is still a good stock at current trading levels. Investors who take the time to do their homework for every trade may find themselves a step ahead of the crowd in the long run.

Big organizations that control vast sums of money, such as mutual funds, insurance companies or pension funds, that buy securities are known as “institutional investors”.  Unlike individual investors, institutional investors trade in massive blocks of 10,000 or more shares per transaction.  The sheer size of these trades significantly affect the price of a share. 

PROS AND CONS

Peter Lynch says in his best-selling book, “One Up on Wall Street”, that institutional ownership is a negative thing.  “Institutions don’t own it and the analysts don’t follow it”.  He favors the stocks that big investment groups pass on because he feels that these stocks are undervalued.  In contrast, Investor’s Business Daily’s William O’Neil thinks that institutional investors are important to driving up stock prices because they provide the largest source of demand for stocks.  O’Neil argues that if a stock has no institutional ownership, it means they have already passed on it.  He regards institutional ownership as a desirable stock trait in his book, “How to Make Money in Stocks”. 

Investors often look favorably upon stocks who have a large amount of institutional ownership.  These large companies often employ a team of analysts to perform financial research before purchasing a large block of stock, making their decisions influential in the eyes of other investors.

Due to the financial commitment that these companies make into research, these institutions aren’t quick to sell off their shares.  But when they do, however, it can drive down the price. 

TECHNICAL ANALYSIS

Technical analysts have little regard for the value of a company. They use historic price data to observe stock price patterns to predict the direction of that price going forward.  Analysts use common formulas and ratios to accomplish this.

Arcadia Biosciences, Inc. (NASDAQ:RKDA)’s RSI (Relative Strength Index) is 42.73.  RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions.

RETURNS AND RECOMMENDATION

Shareholders can expect a return on equity of -360.70%.  Calculated by dividing Arcadia Biosciences, Inc.’s annual earnings by its total assets, investors will note a return on assets of -111.00%.  Finally, Arcadia Biosciences, Inc.’s return on investment stands at -190.50% when you divide the shareholder’s return by the cost.  The consensus analysts recommendation at this point stands at 2.00 for Arcadia Biosciences, Inc. (NASDAQ:RKDA).  This is based on a 1-5 scale where 1 indicates a Strong Buy and 5 a Strong Sell.

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.